These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16082525)

  • 1. [Avoiding emergency situations under anticoagulant therapy with vitamin K antagonists].
    Dempfle CE; Borggrefe M
    Internist (Berl); 2005 Sep; 46(9):1006-10, 1012-3. PubMed ID: 16082525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
    Angelo M; Stockner I; Wiedermann CJ
    Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of vitamin K antagonists prior to urgent surgery.
    Grobler C; Callum J; McCluskey SA
    Can J Anaesth; 2010 May; 57(5):458-67. PubMed ID: 20077167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update of consensus guidelines for warfarin reversal.
    Tran HA; Chunilal SD; Harper PL; Tran H; Wood EM; Gallus AS;
    Med J Aust; 2013 Mar; 198(4):198-9. PubMed ID: 23451962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of vitamin K in anticoagulation reversal for hip fracture surgery--a prospective observational study.
    Buecking B; Eschbach D; Bliemel C; Oberkircher L; Struewer J; Ruchholtz S; Sachs UJ
    Thromb Res; 2014 Jan; 133(1):42-7. PubMed ID: 24196230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discontinuing oral anticoagulation for elective surgical interventions].
    Marzan A; Ulrich Somaini S; Bächli E
    Praxis (Bern 1994); 2011 Nov; 100(23):1387-92; quiz 1393-5. PubMed ID: 22086376
    [No Abstract]   [Full Text] [Related]  

  • 8. Vitamin K antagonists and emergencies.
    Lapostolle F; Siguret V; Martin AC; Pailleret C; Vigué B; Zerbib Y; Tazarourte K
    Eur J Emerg Med; 2018 Dec; 25(6):378-386. PubMed ID: 29462053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).
    Pernod G; Godiér A; Gozalo C; Tremey B; Sié P;
    Thromb Res; 2010 Sep; 126(3):e167-74. PubMed ID: 20630568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of bleeding complications in the anticoagulated patient.
    Bhagirath VC; O'Malley L; Crowther MA
    Semin Hematol; 2011 Oct; 48(4):285-94. PubMed ID: 22000094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to effectively manage the event of bleeding complications when using anticoagulants.
    Sartori MT; Prandoni P
    Expert Rev Hematol; 2016 Jan; 9(1):37-50. PubMed ID: 26573697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.
    Spyropoulos AC; Al-Badri A; Sherwood MW; Douketis JD
    J Thromb Haemost; 2016 May; 14(5):875-85. PubMed ID: 26988871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing anticoagulants both old and new.
    Warkentin TE; Crowther MA
    Can J Anaesth; 2002; 49(6):S11-25. PubMed ID: 12557411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perioperative heparin bridging is rarely indicated].
    Nielsen JD; Münster AM; Husted SE
    Ugeskr Laeger; 2016 Feb; 178(9):V12150952. PubMed ID: 26957485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excessive anticoagulation with warfarin or phenprocoumon may have multiple causes.
    Meegaard PM; Holck LH; Pottegård A; Madsen H; Hallas J
    Dan Med J; 2012 Feb; 59(2):A4383. PubMed ID: 22293053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of excessive anticoagulant effect due to vitamin K antagonists.
    Dentali F; Crowther MA
    Hematology Am Soc Hematol Educ Program; 2008; ():266-70. PubMed ID: 19074094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergent pediatric anticoagulation reversal using a 4-factor prothrombin complex concentrate.
    Adams CB; Vollman KE; Leventhal EL; Acquisto NM
    Am J Emerg Med; 2016 Jun; 34(6):1182.e1-2. PubMed ID: 26652577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.